The future of CBD: Is the hemp market hurtling towards a crash?

Cannabidiol (CBD) may be entering mainstream, but Rabobank analysts argue that legal ambiguities and underregulation are the key deterrents for entrants to this new market

Related Articles

FormattedPicture

BUSINESS NEWS

16 Jul 2021 --- The Natural Products Association (NPA) is welcoming new draft legislation from the US Senate that directs the Food and Drug Administration (FDA) to set an upper... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

14 Jul 2021 --- Consumers across the globe are placing increased emphasis on positive nutrition rather than the more traditional methods of diet control, according to analysis by... Read More

FormattedPicture

REGULATORY NEWS

05 Jul 2021 --- Amid controversy around cannabis use and the Olympics, Fourfive is calling on the UK’s sports governing bodies to start clinical trials into the effectiveness... Read More

FormattedPicture

BUSINESS NEWS

25 Jun 2021 --- Kadenwood, a plant-based wellness company, has acquired UK-based cannabidiol (CBD) wellness brand Healist Advanced Naturals in a bid to help normalize CBD.

FormattedPicture

NUTRITION & HEALTH NEWS

23 Jun 2021 --- DSM is continuing its journey into the cannabinoid space with an exclusive commercial partnership with Brains Bioceutical, which is active in cannabinoid active... Read More

trans